My City Builders, Inc.
Data quality: 100%
MYCB
OTC
Financial Services
Real Estate
$0.04
▼
$0.06
(-60.40%)
Mkt Cap: 717,067.0
Price
$0.04
Mkt Cap
717,067.0
Day Range
$0.04 — $0.04
52-Week Range
$0.04 — $1.10
Volume
1
Open $0.04
50D / 200D Avg
$0.11
62.96% below
50D / 200D Avg
$0.53
92.47% below
Quick Summary
Key Takeaways
Earnings declined -2026.67% over the past year
Net margin of 795.89% shows strong profitability
Negative free cash flow of -205,870.0
Capital efficient — spends only -139.07% of revenue on capex
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)-100.00%
Earnings (1Y)-2026.67%
FCF Growth (3Y)N/A
Quality
Return on Equity
N/A
ROIC-20.84%
Net Margin795.89%
Op. Margin158.73%
Safety
Debt / Equity
N/A
Current Ratio0.87
Interest CoverageN/A
Valuation
PE (TTM)
-1.63
Below sector avg (11.15)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A
Price History
Financial Trends
Peer Comparison
vs Financial Services sector median (2150 peers)
Peer Comparison
vs Financial Services sector median (2150 peers)| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -1.6 | 11.2 |
| P/B | — | 1.2 |
| ROE % | — | 9.2 |
| Net Margin % | 795.9 | 9.4 |
| Rev Growth 5Y % | — | 5.8 |
| D/E | — | 0.5 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -100.00% | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | -2026.67% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | -55,271.0 | Net Income (TTM) | -439,897.0 |
| ROE | N/A | ROA | -113.50% |
| Gross Margin | N/A | Operating Margin | 158.73% |
| Net Margin | 795.89% | Free Cash Flow (TTM) | -205,870.0 |
| ROIC | -20.84% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 0.87 |
| Interest Coverage | N/A | Asset Turnover | -0.14 |
| Working Capital | -7,275 | Tangible Book Value | -7,275 |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -1.63 | Forward P/E | N/A |
| P/B Ratio | N/A | P/S Ratio | -12.97 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -28.71% | ||
| Market Cap | 717,067.0 | Enterprise Value | 717,067.0 |
| Per Share | |||
| EPS (Diluted TTM) | -0.04 | Revenue / Share | 0.00 |
| FCF / Share | -0.01 | OCF / Share | -0.01 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | -139.07% | FCF Conversion | 46.80% |
| SBC-Adj. FCF | N/A | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 59,300.0 | — | — | 0.0 |
| Net Income | -498,315.0 | 25,864.0 | -2.02 M | -23,238.0 | -103,795.0 |
| EPS (Diluted) | -0.04 | — | — | — | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | -103,944.0 | -278,370.0 | -153,275.0 | -23,238.0 | -43,795.0 |
| EBITDA | — | — | — | — | — |
| R&D Expenses | — | — | — | — | — |
| SG&A Expenses | — | — | — | — | — |
| D&A | — | — | — | — | — |
| Interest Expense | — | 19,279.0 | — | — | 60,000.0 |
| Income Tax | 1,128.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 42,812.0 | 3.47 M | 2.25 M | 337,198.0 | 665.0 |
| Total Liabilities | 38,343.0 | 2.31 M | 3.96 M | 28,635.0 | 957,486.0 |
| Shareholders' Equity | 4,469.0 | 1.16 M | -1.71 M | 308,563.0 | -956,821.0 |
| Total Debt | — | 1.38 M | — | — | 500,000.0 |
| Cash & Equivalents | — | — | — | — | — |
| Current Assets | 42,812.0 | 1.64 M | 418,262.0 | 337,198.0 | 665.0 |
| Current Liabilities | 38,343.0 | 1.57 M | 3.96 M | 28,635.0 | 957,486.0 |
{"event":"ticker_viewed","properties":{"ticker":"MYCB","listing_kind":"stock","pathname":"/stocks/mycb","exchange":"OTC","country":"US"}}